EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases

Yvonne M Mueller, Charlotte Girard, Harmen J G van de Werken, Stefan J Erkeland, Dwin G B Grashof iD, Laurie Vaillant, Renske J H den Dekker, Iris van Zuijen, Sharon Veenbergen, Fanny Coffin, Eric Bindels, Yvan Jamilloux iD und 5 weitere

Arthritis & Rheumatology · 2026

DOI: 10.1002/art.70102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, 2026. Verfasst von Yvonne M Mueller und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Interleukin-18, Interferon Type I, Hereditary Autoinflammatory Diseases, Lymphohistiocytosis, Hemophagocytic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Horizon 2020, Horizon 2020 Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The unknown pathophysiology and the lack of specific features for systemic juvenile idiopathic arthritis and adult‐onset Still disease (collectively known as Still disease; SD) delay diagnosis and appropriate treatment. The goal of this study was to identify features and mechanisms that distinguish SD from other systemic autoinflammatory diseases (SAID).

Methods

Using the SomaScan assay and RNA sequencing (RNA‐Seq), we determined the plasma proteomes and immune cell microRNA (miRNA) and RNA transcriptomes of 372 patients with SAID, respectively. Proteomic findings were validated by enzyme‐linked immunosorbent assays. SD (n = 72) and non‐SD SAIDs (n = 300) were compared to identify distinguishing features of SD. We performed integrated and unbiased analyses of all data sets using weighted gene correlation network analysis to identify feature modules that characterize SD and stratify patients.

Results

Elevated plasma heme oxygenase 1 (HO‐1) and interleukin‐18 (IL‐18) strongly correlate and characterize SD but do not associate with general inflammation. SD was characterized by ferroptosis in plasma, type I interferon (IFN) signaling in monocyte transcriptomes, and elevated natural killer cell miRNA‐146a‐5p, which is an IL‐18 induced miRNA. Finally, we identified feature modules that distinguish SD from other SAIDs and stratified patients with SD into two distinct subgroups not attributable to disease activity or inflammation but hemophagocytosis.

Conclusion

This unprecedented large omics data set of SAIDs revealed that complex interactions among hemophagocytosis, IL‐18, and type I IFN signaling characterize SD. Furthermore, two distinct subgroups in patients with SD were distinguished by the degree of hemophagocytic activity. Finally, the large proteomics and RNA‐Seq data sets generated in this study can serve as an invaluable resource for the further investigation of SD and other SAIDs. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-18Interferon Type IHereditary Autoinflammatory DiseasesLymphohistiocytosis, HemophagocyticHumansFemaleMicroRNAsMaleHeme Oxygenase-1AdultArthritis, JuvenileProteomicsAdolescentChildDiagnosis, Differential

Substanzen

Interleukin-18Interferon Type IMicroRNAsHeme Oxygenase-1IL18 protein, human

Autor:innen und Institutionen

  • Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Department of Internal Medicine, University of Geneva, Geneva, Switzerland.
  • Institut Curie, Paris, France, Research University, Paris, France, Mines Paris Tech, Fontainebleau, France.
  • Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Department of Internal Medicine, University Hospital Croix-Rousse, Hospices Civils de Lyon, University of Lyon, Lyon, France, Centre International de Recherche en Infectiologie (CIRI), Inserm U1111, ENS/CNRS UMR5308, Ly…
  • Rheumatology Unit, First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, University of Athens, Medical School, Athens, Greece.

ORCID-Profile: Dwin G B Grashof, Yvan Jamilloux, Katerina Laskari, Peter D Katsikis

Förderung

  • Horizon 2020
  • Horizon 2020 Framework Programme

Zitieren

APA

Mueller, Y. M., Girard, C., van de Werken, H. J. G., Erkeland, S. J., Grashof, D. G. B., Vaillant, L., den Dekker, R. J. H., van Zuijen, I., Veenbergen, S., Coffin, F., Bindels, E., Jamilloux, Y., Laskari, K., Soumelis, V., Fautrel, B., Gabay, C., & Katsikis, P. D. (2026). A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases. Arthritis & Rheumatology. https://doi.org/10.1002/art.70102

Vancouver

Mueller YM, Girard C, van de Werken HJG, Erkeland SJ, Grashof DGB, Vaillant L, et al. A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases. Arthritis & Rheumatology. 2026. doi:10.1002/art.70102

BibTeX
@article{Mueller2026,
  author = {Mueller, Yvonne M and Girard, Charlotte and van de Werken, Harmen J G and Erkeland, Stefan J and Grashof, Dwin G B and Vaillant, Laurie and den Dekker, Renske J H and van Zuijen, Iris and Veenbergen, Sharon and Coffin, Fanny and Bindels, Eric and Jamilloux, Yvan and Laskari, Katerina and Soumelis, Vassili and Fautrel, Bruno and Gabay, Cem and Katsikis, Peter D},
  title = {A Multifaceted Interplay Among Hemophagocytosis, Interleukin‐18, and Type I Interferon Distinguishes Still Disease From Other Autoinflammatory Diseases},
  journal = {Arthritis & Rheumatology},
  year = {2026},
  doi = {10.1002/art.70102}
}
Kostenlos starten →